SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'ZEN'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1AQ7_B_AG2B4_1 (TRYPSIN AERUGINOSIN 98-B)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	6 / 8	HIS T 57 ASP T 189 SER T 195 VAL T 213 GLY T 216 GLY T 226	SO4 T 600 (-3.8A) ZEN T 1 ( 3.8A) SO4 T 600 ( 2.6A) ZEN T 1 (-4.1A) ZEN T 1 (-3.7A) ZEN T 1 (-3.7A)	0.46A	1aq7A-1j17T: 42.9	1aq7A-1j17T: 71.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BCU_H_PRLH280_0 (ALPHA-THROMBIN)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	7 / 9	ASP T 189 ALA T 190 SER T 195 VAL T 213 TRP T 215 GLY T 216 GLY T 226	ZEN T 1 ( 3.8A) ZEN T 1 (-3.8A) SO4 T 600 ( 2.6A) ZEN T 1 (-4.1A) ZEN T 1 (-3.4A) ZEN T 1 (-3.7A) ZEN T 1 (-3.7A)	0.32A	1bcuH-1j17T: 18.7	1bcuH-1j17T: 37.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1DWC_H_MITH1_1 (ALPHA-THROMBIN (LARGE SUBUNIT))	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	5 / 9	HIS T 57 ASP T 189 SER T 195 TRP T 215 GLY T 226	SO4 T 600 (-3.8A) ZEN T 1 ( 3.8A) SO4 T 600 ( 2.6A) ZEN T 1 (-3.4A) ZEN T 1 (-3.7A)	0.37A	1dwcH-1j17T: 34.3	1dwcH-1j17T: 37.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ETR_H_MITH1_1 (EPSILON-THROMBIN)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	7 / 12	HIS T 57 ASP T 189 SER T 195 VAL T 213 TRP T 215 GLY T 216 GLY T 226	SO4 T 600 (-3.8A) ZEN T 1 ( 3.8A) SO4 T 600 ( 2.6A) ZEN T 1 (-4.1A) ZEN T 1 (-3.4A) ZEN T 1 (-3.7A) ZEN T 1 (-3.7A)	0.49A	1etrH-1j17T: 34.4	1etrH-1j17T: 38.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1F5L_A_AMRA301_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	6 / 8	ASP T 189 GLN T 192 SER T 195 VAL T 213 GLY T 216 GLY T 226	ZEN T 1 ( 3.8A) None SO4 T 600 ( 2.6A) ZEN T 1 (-4.1A) ZEN T 1 (-3.7A) ZEN T 1 (-3.7A)	0.50A	1f5lA-1j17T: 15.2	1f5lA-1j17T: 36.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1TNL_A_TPAA900_1 (TRYPSIN)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	5 / 6	ASP T 189 SER T 195 VAL T 213 GLY T 216 GLY T 226	ZEN T 1 ( 3.8A) SO4 T 600 ( 2.6A) ZEN T 1 (-4.1A) ZEN T 1 (-3.7A) ZEN T 1 (-3.7A)	0.20A	1tnlA-1j17T: 43.0	1tnlA-1j17T: 71.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NMZ_B_ROCB401_1 (PROTEASE)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	6 / 12	LEU T 137 GLY T 19 ASP T 189 GLY T 142 PRO T 198 ILE T 138	None None ZEN T 1 ( 3.8A) None None None	1.21A	2nmzA-1j17T: undetectable	2nmzA-1j17T: 17.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OTV_A_NCAA1301_0 (CATIONIC TRYPSIN)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	5 / 6	ASP T 189 SER T 195 VAL T 213 GLY T 216 GLY T 226	ZEN T 1 ( 3.8A) SO4 T 600 ( 2.6A) ZEN T 1 (-4.1A) ZEN T 1 (-3.7A) ZEN T 1 (-3.7A)	0.13A	2otvA-1j17T: 43.0	2otvA-1j17T: 71.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2P16_A_GG2A298_1 (COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR))	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	10 / 12	TYR T 99 PHE T 174 ASP T 189 ALA T 190 SER T 195 VAL T 213 TRP T 215 GLY T 216 GLY T 226 TYR T 228	ZEN T 1 (-3.8A) ZEN T 1 (-3.8A) ZEN T 1 ( 3.8A) ZEN T 1 (-3.8A) SO4 T 600 ( 2.6A) ZEN T 1 (-4.1A) ZEN T 1 (-3.4A) ZEN T 1 (-3.7A) ZEN T 1 (-3.7A) ZEN T 1 (-3.6A)	0.37A	2p16A-1j17T: 36.4	2p16A-1j17T: 39.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VIN_A_505A1247_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	6 / 8	ASP T 189 GLN T 192 SER T 195 VAL T 213 GLY T 216 GLY T 226	ZEN T 1 ( 3.8A) None SO4 T 600 ( 2.6A) ZEN T 1 (-4.1A) ZEN T 1 (-3.7A) ZEN T 1 (-3.7A)	0.72A	2vinA-1j17T: 14.5	2vinA-1j17T: 36.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W26_A_RIVA1001_1 (ACTIVATED FACTOR XA HEAVY CHAIN)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	11 / 12	TYR T 99 PHE T 174 ASP T 189 ALA T 190 SER T 195 VAL T 213 TRP T 215 GLY T 216 GLY T 219 GLY T 226 TYR T 228	ZEN T 1 (-3.8A) ZEN T 1 (-3.8A) ZEN T 1 ( 3.8A) ZEN T 1 (-3.8A) SO4 T 600 ( 2.6A) ZEN T 1 (-4.1A) ZEN T 1 (-3.4A) ZEN T 1 (-3.7A) ZEN T 1 (-4.5A) ZEN T 1 (-3.7A) ZEN T 1 (-3.6A)	0.40A	2w26A-1j17T: 14.3	2w26A-1j17T: 39.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GY3_A_PNTA246_0 (CATIONIC TRYPSIN)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	6 / 11	HIS T 57 ASP T 189 SER T 195 TRP T 215 GLY T 216 GLY T 226	SO4 T 600 (-3.8A) ZEN T 1 ( 3.8A) SO4 T 600 ( 2.6A) ZEN T 1 (-3.4A) ZEN T 1 (-3.7A) ZEN T 1 (-3.7A)	0.29A	3gy3A-1j17T: 41.7	3gy3A-1j17T: 71.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3L8L_D_DVAD8_0 (GRAMICIDIN D)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	3 / 3	VAL T 227 VAL T 213 TRP T 215	None ZEN T 1 (-4.1A) ZEN T 1 (-3.4A)	0.95A	3l8lC-1j17T: undetectable 3l8lD-1j17T: undetectable	3l8lC-1j17T: 5.12 3l8lD-1j17T: 6.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MB5_A_SAMA301_0 (SAM-DEPENDENT METHYLTRANSFERASE)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	5 / 12	ILE T 212 VAL T 213 GLY T 44 ALA T 55 ILE T 73	None ZEN T 1 (-4.1A) None None None	0.97A	3mb5A-1j17T: undetectable	3mb5A-1j17T: 21.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	5 / 6	SER T 195 VAL T 213 TRP T 215 GLY T 216 GLY T 226	SO4 T 600 ( 2.6A) ZEN T 1 (-4.1A) ZEN T 1 (-3.4A) ZEN T 1 (-3.7A) ZEN T 1 (-3.7A)	0.18A	3rxfA-1j17T: 43.1	3rxfA-1j17T: 71.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXH_A_HSMA7_1 (CATIONIC TRYPSIN)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	4 / 5	ASP T 189 SER T 195 VAL T 213 GLY T 226	ZEN T 1 ( 3.8A) SO4 T 600 ( 2.6A) ZEN T 1 (-4.1A) ZEN T 1 (-3.7A)	0.24A	3rxhA-1j17T: 43.1	3rxhA-1j17T: 71.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W67_B_VIVB301_0 (ALPHA-TOCOPHEROL TRANSFER PROTEIN)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	5 / 12	ILE T 89 VAL T 213 ILE T 242 ILE T 47 LEU T 209	None ZEN T 1 (-4.1A) None None None	1.01A	3w67B-1j17T: undetectable	3w67B-1j17T: 21.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HFP_D_15UD402_1 (PROTHROMBIN)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	6 / 12	HIS T 57 ASP T 189 ALA T 190 VAL T 213 TRP T 215 GLY T 226	SO4 T 600 (-3.8A) ZEN T 1 ( 3.8A) ZEN T 1 (-3.8A) ZEN T 1 (-4.1A) ZEN T 1 (-3.4A) ZEN T 1 (-3.7A)	0.28A	4hfpD-1j17T: 34.3	4hfpD-1j17T: 37.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RN6_B_15UB301_1 (THROMBIN HEAVY CHAIN)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	6 / 12	HIS T 57 ALA T 190 VAL T 213 TRP T 215 GLY T 216 GLY T 226	SO4 T 600 (-3.8A) ZEN T 1 (-3.8A) ZEN T 1 (-4.1A) ZEN T 1 (-3.4A) ZEN T 1 (-3.7A) ZEN T 1 (-3.7A)	0.72A	4rn6B-1j17T: 28.7	4rn6B-1j17T: 37.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KBW_A_RBFA201_1 (RIBOFLAVIN TRANSPORTER RIBU)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	5 / 12	LEU T 185 ASP T 189 GLY T 226 ASN T 224 ALA T 170	None ZEN T 1 ( 3.8A) ZEN T 1 (-3.7A) None None	1.42A	5kbwA-1j17T: undetectable	5kbwA-1j17T: 20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KC0_A_RBFA303_1 (RIBOFLAVIN TRANSPORTER RIBU)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	5 / 12	LEU T 185 ASP T 189 GLY T 226 ASN T 224 ALA T 170	None ZEN T 1 ( 3.8A) ZEN T 1 (-3.7A) None None	1.41A	5kc0A-1j17T: undetectable	5kc0A-1j17T: 21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HU9_H_PCFH604_0 (CYTOCHROME B-C1 COMPLEX SUBUNIT 8 CYTOCHROME C OXIDASE POLYPEPTIDE 5A, MITOCHONDRIAL)	1j17	TRYPSIN II, ANIONIC (Rattus norvegicus)	5 / 8	GLY T 216 VAL T 183 GLY T 193 SER T 195 ALA T 55	ZEN T 1 (-3.7A) None SO4 T 600 (-3.8A) SO4 T 600 ( 2.6A) None	1.39A	6hu9H-1j17T: undetectable 6hu9e-1j17T: undetectable	6hu9H-1j17T: 14.69 6hu9e-1j17T: 22.87

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AQ7_B_AG2B4_1","TRYPSIN;AERUGINOSIN 98-B","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",6,"HIS T  57;ASP T 189;SER T 195;VAL T 213;GLY T 216;GLY T 226","SO4 T 600 (-3.8A);ZEN T   1 ( 3.8A);SO4 T 600 ( 2.6A);ZEN T   1 (-4.1A);ZEN T   1 (-3.7A);ZEN T   1 (-3.7A)","0.46A","1aq7A-1j17T:42.9",null],["1BCU_H_PRLH280_0","ALPHA-THROMBIN","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",7,"ASP T 189;ALA T 190;SER T 195;VAL T 213;TRP T 215;GLY T 216;GLY T 226","ZEN T   1 ( 3.8A);ZEN T   1 (-3.8A);SO4 T 600 ( 2.6A);ZEN T   1 (-4.1A);ZEN T   1 (-3.4A);ZEN T   1 (-3.7A);ZEN T   1 (-3.7A)","0.32A","1bcuH-1j17T:18.7","1aq7A-1j17T:71.75"],["1DWC_H_MITH1_1","ALPHA-THROMBIN (LARGE SUBUNIT)","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",5,"HIS T  57;ASP T 189;SER T 195;TRP T 215;GLY T 226","SO4 T 600 (-3.8A);ZEN T   1 ( 3.8A);SO4 T 600 ( 2.6A);ZEN T   1 (-3.4A);ZEN T   1 (-3.7A)","0.37A","1dwcH-1j17T:34.3","1bcuH-1j17T:37.74"],["1ETR_H_MITH1_1","EPSILON-THROMBIN","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",7,"HIS T  57;ASP T 189;SER T 195;VAL T 213;TRP T 215;GLY T 216;GLY T 226","SO4 T 600 (-3.8A);ZEN T   1 ( 3.8A);SO4 T 600 ( 2.6A);ZEN T   1 (-4.1A);ZEN T   1 (-3.4A);ZEN T   1 (-3.7A);ZEN T   1 (-3.7A)","0.49A","1etrH-1j17T:34.4","1dwcH-1j17T:37.74"],["1F5L_A_AMRA301_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",6,"ASP T 189;GLN T 192;SER T 195;VAL T 213;GLY T 216;GLY T 226","ZEN T   1 ( 3.8A);None;SO4 T 600 ( 2.6A);ZEN T   1 (-4.1A);ZEN T   1 (-3.7A);ZEN T   1 (-3.7A)","0.50A","1f5lA-1j17T:15.2","1etrH-1j17T:38.55"],["1TNL_A_TPAA900_1","TRYPSIN","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",5,"ASP T 189;SER T 195;VAL T 213;GLY T 216;GLY T 226","ZEN T   1 ( 3.8A);SO4 T 600 ( 2.6A);ZEN T   1 (-4.1A);ZEN T   1 (-3.7A);ZEN T   1 (-3.7A)","0.20A","1tnlA-1j17T:43.0","1f5lA-1j17T:36.95"],["2NMZ_B_ROCB401_1","PROTEASE;PROTEASE","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",6,"LEU T 137;GLY T  19;ASP T 189;GLY T 142;PRO T 198;ILE T 138","None;None;ZEN T   1 ( 3.8A);None;None;None","1.21A","2nmzA-1j17T:undetectable","1tnlA-1j17T:71.75"],["2OTV_A_NCAA1301_0","CATIONIC TRYPSIN","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",5,"ASP T 189;SER T 195;VAL T 213;GLY T 216;GLY T 226","ZEN T   1 ( 3.8A);SO4 T 600 ( 2.6A);ZEN T   1 (-4.1A);ZEN T   1 (-3.7A);ZEN T   1 (-3.7A)","0.13A","2otvA-1j17T:43.0","2nmzA-1j17T:17.54"],["2P16_A_GG2A298_1","COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR)","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",10,"TYR T  99;PHE T 174;ASP T 189;ALA T 190;SER T 195;VAL T 213;TRP T 215;GLY T 216;GLY T 226;TYR T 228","ZEN T   1 (-3.8A);ZEN T   1 (-3.8A);ZEN T   1 ( 3.8A);ZEN T   1 (-3.8A);SO4 T 600 ( 2.6A);ZEN T   1 (-4.1A);ZEN T   1 (-3.4A);ZEN T   1 (-3.7A);ZEN T   1 (-3.7A);ZEN T   1 (-3.6A)","0.37A","2p16A-1j17T:36.4","2otvA-1j17T:71.75"],["2VIN_A_505A1247_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",6,"ASP T 189;GLN T 192;SER T 195;VAL T 213;GLY T 216;GLY T 226","ZEN T   1 ( 3.8A);None;SO4 T 600 ( 2.6A);ZEN T   1 (-4.1A);ZEN T   1 (-3.7A);ZEN T   1 (-3.7A)","0.72A","2vinA-1j17T:14.5","2p16A-1j17T:39.50"],["2W26_A_RIVA1001_1","ACTIVATED FACTOR XA HEAVY CHAIN","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",11,"TYR T  99;PHE T 174;ASP T 189;ALA T 190;SER T 195;VAL T 213;TRP T 215;GLY T 216;GLY T 219;GLY T 226;TYR T 228","ZEN T   1 (-3.8A);ZEN T   1 (-3.8A);ZEN T   1 ( 3.8A);ZEN T   1 (-3.8A);SO4 T 600 ( 2.6A);ZEN T   1 (-4.1A);ZEN T   1 (-3.4A);ZEN T   1 (-3.7A);ZEN T   1 (-4.5A);ZEN T   1 (-3.7A);ZEN T   1 (-3.6A)","0.40A","2w26A-1j17T:14.3","2vinA-1j17T:36.95"],["3GY3_A_PNTA246_0","CATIONIC TRYPSIN","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",6,"HIS T  57;ASP T 189;SER T 195;TRP T 215;GLY T 216;GLY T 226","SO4 T 600 (-3.8A);ZEN T   1 ( 3.8A);SO4 T 600 ( 2.6A);ZEN T   1 (-3.4A);ZEN T   1 (-3.7A);ZEN T   1 (-3.7A)","0.29A","3gy3A-1j17T:41.7","2w26A-1j17T:39.50"],["3L8L_D_DVAD8_0","GRAMICIDIN D","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",3,"VAL T 227;VAL T 213;TRP T 215","None;ZEN T   1 (-4.1A);ZEN T   1 (-3.4A)","0.95A","3l8lC-1j17T:undetectable;3l8lD-1j17T:undetectable","3gy3A-1j17T:71.75"],["3MB5_A_SAMA301_0","SAM-DEPENDENT METHYLTRANSFERASE","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",5,"ILE T 212;VAL T 213;GLY T  44;ALA T  55;ILE T  73","None;ZEN T   1 (-4.1A);None;None;None","0.97A","3mb5A-1j17T:undetectable","3l8lC-1j17T:5.12;3l8lD-1j17T:6.05"],["3RXF_A_4APA9_1","CATIONIC TRYPSIN","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",5,"SER T 195;VAL T 213;TRP T 215;GLY T 216;GLY T 226","SO4 T 600 ( 2.6A);ZEN T   1 (-4.1A);ZEN T   1 (-3.4A);ZEN T   1 (-3.7A);ZEN T   1 (-3.7A)","0.18A","3rxfA-1j17T:43.1","3mb5A-1j17T:21.91"],["3RXH_A_HSMA7_1","CATIONIC TRYPSIN","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",4,"ASP T 189;SER T 195;VAL T 213;GLY T 226","ZEN T   1 ( 3.8A);SO4 T 600 ( 2.6A);ZEN T   1 (-4.1A);ZEN T   1 (-3.7A)","0.24A","3rxhA-1j17T:43.1","3rxfA-1j17T:71.75"],["3W67_B_VIVB301_0","ALPHA-TOCOPHEROL TRANSFER PROTEIN","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",5,"ILE T  89;VAL T 213;ILE T 242;ILE T  47;LEU T 209","None;ZEN T   1 (-4.1A);None;None;None","1.01A","3w67B-1j17T:undetectable","3rxhA-1j17T:71.75"],["4HFP_D_15UD402_1","PROTHROMBIN","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",6,"HIS T  57;ASP T 189;ALA T 190;VAL T 213;TRP T 215;GLY T 226","SO4 T 600 (-3.8A);ZEN T   1 ( 3.8A);ZEN T   1 (-3.8A);ZEN T   1 (-4.1A);ZEN T   1 (-3.4A);ZEN T   1 (-3.7A)","0.28A","4hfpD-1j17T:34.3","3w67B-1j17T:21.99"],["4RN6_B_15UB301_1","THROMBIN HEAVY CHAIN","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",6,"HIS T  57;ALA T 190;VAL T 213;TRP T 215;GLY T 216;GLY T 226","SO4 T 600 (-3.8A);ZEN T   1 (-3.8A);ZEN T   1 (-4.1A);ZEN T   1 (-3.4A);ZEN T   1 (-3.7A);ZEN T   1 (-3.7A)","0.72A","4rn6B-1j17T:28.7","4hfpD-1j17T:37.35"],["5KBW_A_RBFA201_1","RIBOFLAVIN TRANSPORTER RIBU","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",5,"LEU T 185;ASP T 189;GLY T 226;ASN T 224;ALA T 170","None;ZEN T   1 ( 3.8A);ZEN T   1 (-3.7A);None;None","1.42A","5kbwA-1j17T:undetectable","4rn6B-1j17T:37.35"],["5KC0_A_RBFA303_1","RIBOFLAVIN TRANSPORTER RIBU","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",5,"LEU T 185;ASP T 189;GLY T 226;ASN T 224;ALA T 170","None;ZEN T   1 ( 3.8A);ZEN T   1 (-3.7A);None;None","1.41A","5kc0A-1j17T:undetectable","5kbwA-1j17T:20.92"],["6HU9_H_PCFH604_0","CYTOCHROME B-C1 COMPLEX SUBUNIT 8;CYTOCHROME C OXIDASE POLYPEPTIDE 5A, MITOCHONDRIAL","1j17","TRYPSIN II, ANIONIC","Rattus norvegicus",5,"GLY T 216;VAL T 183;GLY T 193;SER T 195;ALA T  55","ZEN T   1 (-3.7A);None;SO4 T 600 (-3.8A);SO4 T 600 ( 2.6A);None","1.39A","6hu9H-1j17T:undetectable;6hu9e-1j17T:undetectable","5kc0A-1j17T:21.55"]]